Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypereosinophilic Syndrome”

142 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 142 results

Testing effectiveness (Phase 2)Study completedNCT00171912
What this trial is testing

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

Who this might be right for
Hypereosinophilic SyndromeSystemic MastocytosisChronic Myelomonocytic Leukemia+1 more
Novartis Pharmaceuticals 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07250594
What this trial is testing

A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
Advagene Biopharma Co. Ltd. 126
Not applicableNot Yet RecruitingNCT05762627
What this trial is testing

Severe Eosinophilic Asthma Phenotypes During Childhood Have Various Origins

Who this might be right for
Severe AsthmaAsthma in Children
Assistance Publique - Hôpitaux de Paris 360
Not applicableLooking for participantsNCT07275190
What this trial is testing

The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome

Who this might be right for
EGPA - Eosinophilic Granulomatosis With PolyangiitisHES - Hypereosinophilic Syndrome
Fondazione IRCCS Policlinico San Matteo di Pavia 60
Not applicableUnknownNCT04924478
What this trial is testing

Evaluation of Volatile Organic Compounds in Mepolizumab Therapy

Who this might be right for
Asthma; Eosinophilic
University Hospital Southampton NHS Foundation Trust 60
Not applicableNot Yet RecruitingNCT06676397
What this trial is testing

Homeostatic Roles of Eosinophils in Asthma

Who this might be right for
Asthma; Eosinophilic
Centre Hospitalier Universitaire de Besancon 100
Not applicableStudy completedNCT05271526
What this trial is testing

Real World Evidence of Benralizumab in Eosinophilic Severe AsThma in Russia (BEST)

Who this might be right for
Severe Eosinophilic Asthma
AstraZeneca 3
Not applicableStudy completedNCT06172751
What this trial is testing

TrinetX Study of Hypereosinophilic Syndrome (HES) Without an Identifiable Non-haematological Secondary Cause

Who this might be right for
Hypereosinophilic Syndrome (HES)
AstraZeneca 250
Not applicableUnknownNCT04897113
What this trial is testing

Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old

Who this might be right for
HypercholesterolemiaHyperbilirubinemiaHyper IgE Syndrome+9 more
National Medical Research Center for Rehabilitation and Balneology 80
Large-scale testing (Phase 3)Looking for participantsNCT05334368
What this trial is testing

Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

Who this might be right for
Hypereosinophilic Syndrome
GlaxoSmithKline 109
Not applicableNot Yet RecruitingNCT07174713
What this trial is testing

REverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM)

Who this might be right for
Asthma; Eosinophilic
Western University, Canada 200
Large-scale testing (Phase 3)Active Not RecruitingNCT05748600
What this trial is testing

Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

Who this might be right for
Eosinophilic AsthmaAsthma; EosinophilicAsthma Attack
Areteia Therapeutics 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT03801434
What this trial is testing

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

Who this might be right for
BCR-JAK2 Fusion Protein ExpressionBlasts 20 Percent or Less of Peripheral Blood White CellsBlasts More Than 5 Percent of Bone Marrow Nucleated Cells+9 more
Stanford University 8
Not applicableStudy completedNCT04181190
What this trial is testing

Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients

Who this might be right for
AsthmaAsthma; Eosinophilic
Università degli Studi di Ferrara 130
Not applicableStudy completedNCT05091385
What this trial is testing

Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma

Who this might be right for
Asthma; Eosinophilic
Medical University of Lodz 106
Not applicableNo Longer AvailableNCT04498871
What this trial is testing

MAP to Provide Access to Nilotinib, for Patients With HES

Who this might be right for
Hypereosinophilic Syndrome (HES)
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT01270464
What this trial is testing

Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
Teva Branded Pharmaceutical Products R&D, Inc. 315
Testing effectiveness (Phase 2)Active Not RecruitingNCT00044304
What this trial is testing

Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome

Who this might be right for
Eosinophilic Myeloid NeoplasmHypereosinophilic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 70
Not applicableLooking for participantsNCT00091871
What this trial is testing

A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

Who this might be right for
EosinophiliaHypereosinophilic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableStudy completedNCT03209934
What this trial is testing

Daptomycin > 6 mg/kg/Day as Salvage Therapy in Patients With Complex Bone and Joint Infection: Cohort Study in a Regionalreference Center

Who this might be right for
Bone and Joint InfectionTreated by Daptomycin
Hospices Civils de Lyon 43
Next Page